Hallucinogens

Home
About
Help
History (1)
- Hallucinogens
- See All Pages

"Hallucinogens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise.

Descriptor ID	D006213
MeSH Number(s)	D27.505.696.388 D27.505.954.427.700.372
Concept/Terms	Hallucinogens Hallucinogens Psychotomimetic Agents Agents, Psychotomimetic Hallucinogenic Agents Agents, Hallucinogenic Hallucinogenic Substances Substances, Hallucinogenic Psychedelics Psychedelic Agents Agents, Psychedelic Hallucinogenic Drugs Drugs, Hallucinogenic

Below are MeSH descriptors whose meaning is more general than "Hallucinogens".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Physiological Effects of Drugs [D27.505.696]
Hallucinogens [D27.505.696.388]
Therapeutic Uses [D27.505.954]
Central Nervous System Agents [D27.505.954.427]
Psychotropic Drugs [D27.505.954.427.700]
Hallucinogens [D27.505.954.427.700.372]

Below are MeSH descriptors whose meaning is more specific than "Hallucinogens".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Hallucinogens" by people in this website by year, and whether "Hallucinogens" was a major or minor topic of these publications.

Bar chart showing 13 publications over 8 distinct years, with a maximum of 4 publications in 2006

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2004	1	1	2
2006	4	0	4
2007	0	1	1
2009	2	0	2
2012	0	1	1
2021	1	0	1
2022	1	0	1
2023	1	0	1

Below are the most recent publications written about "Hallucinogens" by people in Profiles.

Cohen N, Mathew M, Brent J, Wax P, Davis AL, Obilom C, Burns MM, Canning J, Baumgartner K, Koons AL, Wiegand TJ, Judge B, Hoyte C, Chenoweth JA, Froberg B, Farrar H, Carey JL, Hendrickson RG, Hodgman M, Caravati EM, Christian MR, Wolk BJ, Seifert SA, Bentur Y, Levine M, Farrugia LA, Vearrier D, Minns AB, Kennedy JM, Kirschner RI, Aldy K, Schuh S, Campleman S, Li S, Myran DT, Feng L, Freedman SB, Finkelstein Y. Severe outcomes following pediatric cannabis intoxication: a prospective cohort study of an international toxicology surveillance registry. Clin Toxicol (Phila). 2023 08; 61(8):591-598.

View in: PubMed
Kaczor EE, Greene K, Zacharia J, Tormoehlen L, Neavyn M, Carreiro S. The Potential Proconvulsant Effects of Cannabis: a Scoping Review. J Med Toxicol. 2022 07; 18(3):223-234.

View in: PubMed
Tolan NV, Terebo T, Chai PR, Erickson TB, Hayes BD, Uljon SN, Petrides AK, Demetriou CA, Melanson SEF. Impact of marijuana legalization on cannabis-related visits to the emergency department. Clin Toxicol (Phila). 2022 May; 60(5):585-595.

View in: PubMed
Roseman AS, McGregor C, Thornton JE. Estradiol attenuates the cognitive deficits in the novel object recognition task induced by sub-chronic phencyclidine in ovariectomized rats. Behav Brain Res. 2012 Jul 15; 233(1):105-12.

View in: PubMed
Biezonski DK, Meyer JS. Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity. J Neurochem. 2010 Feb; 112(4):951-62.

View in: PubMed
Piper BJ, Farelli JD, Meyer JS. Dissociation between serotonin neurotoxicity and brain-derived neurotrophic factor induction following neonatal MDMA exposure in rats. Dev Neurosci. 2009; 31(1-2):90-4.

View in: PubMed
Miguel CF, Yang HG, Finn HE, Ahearn WH. Establishing derived textual control in activity schedules with children with autism. J Appl Behav Anal. 2009; 42(3):703-9.

View in: PubMed
Piper BJ, Fraiman JB, Owens CB, Ali SF, Meyer JS. Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopram. Neuropsychopharmacology. 2008 Apr; 33(5):1192-205.

View in: PubMed
Meyer JS, Brevard ME, Piper BJ, Ali SF, Ferris CF. Neural effects of MDMA as determined by functional magnetic resonance imaging and magnetic resonance spectroscopy in awake marmoset monkeys. Ann N Y Acad Sci. 2006 Aug; 1074:365-76.

View in: PubMed
Warner EA, Friedmann PD. Laboratory testing for drug abuse. Arch Pediatr Adolesc Med. 2006 Aug; 160(8):854, author reply 854.

View in: PubMed

People

Explore

Similar Concepts

Top Journals